NeutraKine® BMP-7 Monoclonal antibody
NeutraKine® BMP-7 Monoclonal Antibody for FC (Intra), Neutralization, ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human, mouse
Applications
FC (Intra), Neutralization, ELISA
Conjugate
Unconjugated
CloneNo.
3E9G7
验证数据展示
Neutralization |
产品信息
69011-1-Ig targets NeutraKine® BMP-7 in FC (Intra), Neutralization, ELISA applications and shows reactivity with human, mouse samples.
Tested Applications | FC (Intra), Neutralization, ELISA Application Description |
Tested Reactivity | human, mouse |
Immunogen | human Humankine BMP-7 protein HZ-1229 种属同源性预测 |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Full Name | bone morphogenetic protein 7 |
Synonyms | BMP7, Eptotermin alfa, Bone morphogenetic protein 7, BMP-7, BMP 7 |
Gene Symbol | BMP7 |
Gene ID (NCBI) | 655 |
RRID | AB_2882929 |
Conjugate | Unconjugated |
Form | Lyophilized Powder |
Purification Method | Protein G purification |
Storage Buffer | Sterile PBS. |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
背景介绍
BMP7, also known as osteogenic protein-1 or OP-1, plays a key role in the transformation of mesenchymal cells into bone and cartilage. BMP7 may be involved in bone homeostasis (PMID: 15621726). It is expressed in the brain, kidneys and bladder. BMP7 is also present in cancers, including breast, prostate, and colon cancers, in which it is implicated in regulating cancer cell proliferation (PMID: 16419056, PMID: 15531927). Overexpression of BMP7 mRNA in colorectal cancer patients was significantly associated with poor prognosis and low overall survival (PMID: 18259822). Recent studies suggest that high-expression level of BMP7 serves as a biomarker for poor prognosis for HCC (PMID: 23179403).
This antibody can be used to neutralize the bioactivity of BMP-7.